CLPT

ClearPoint Neuro, Inc. Common Stock

Nasdaq · usd

$9.04-0.10 (-1.09%)

As of 4:10:04 PM EDT on Oct 26, 2026 · 15-minute delayed

ClearPoint Neuro, Inc. Common Stock (CLPT) trades at $9.04 (-1.09%) as of 4:10:04 PM EDT on Oct 26, 2026, -39.04% over the past month. Market cap is $278.81M, with 6.0 days to cover in short interest.

Stock performance

How ClearPoint Neuro, Inc. Common Stock (CLPT) stock has performed from one day to one year, with its 52-week range.

-1.09%

-$0.10 over 1D

1D: -1.09%
1W: -1.42%
1M: -39.04%
YTD: -33.92%
1Y: -64.49%
52-wk range: $8.27 – $27.27

Key statistics

Today's trading snapshot for CLPT: day range, open, previous close, volume and market cap.

Day range: $8.91 – $9.17
Open: $9.17
Prev close: $9.14
Volume: 455.58K
Market cap: $278.81M
Shares out: 30.5M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for ClearPoint Neuro, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E: —
P/S: 6.59
P/B: 25.87
P/FCF: —
ROE: -320.8%
ROA: -39.9%
Debt/Equity: 4.66
Div yield: 0.00%

As of Oct 23, 2026

Insider buying and selling

In the 12 months to Oct 26, 2026, 2 CLPT insiders reported open-market sales of $2.3M across 6 filings; no open-market purchases were filed.

Who traded CLPT, and when

Sale
Sale, pre-arranged (10b5-1)

CLPT daily closelast $9.04

Joseph Burnett · CEO and President

$2.2M sold

Matthew B. Klein · Director

$185.4K sold

One row per insider; marks sit at the SEC filing date, sized by dollar value.

See who traded and when →

8-K filings

Material corporate events ClearPoint Neuro, Inc. Common Stock has disclosed to the SEC on Form 8-K.

Investor presentationAug 3, 2026
On August 3, 2026, the Company posted an updated investor presentation to its website at https://ir.clearpointneuro.com/news-events/presentations. A copy of the investor presentation is being furnished herewith as Exhibit 99.2. The Company may use the investor presentation from time to time in conversations with analysts, investors and others.
Annual meeting resultsMay 21, 2026
At the Annual Meeting, the Company's stockholders considered and voted on the following proposals... Each proposal was approved and the final voting results for each proposal are described below.
Investor presentationMay 13, 2026
On May 13, 2026, the Company posted an updated investor presentation to its website at http://ir.stockpr.com/clearpointneuro/investor-presentations. The Company may use the investor presentation from time to time in conversations with analysts, investors and others.
Investor presentationMar 17, 2026
On March 17, 2026, the Company posted an updated investor presentation to its website at http://ir.stockpr.com/clearpointneuro/investor-presentations. The Company may use the investor presentation from time to time in conversations with analysts, investors and others.
Preliminary resultsJan 12, 2026
On January 12, 2026, ClearPoint Neuro, Inc. (the "Company") issued a press release announcing its preliminary, unaudited financial results for the fourth fiscal quarter ended December 31, 2025.

Dividend history and stock splits

ClearPoint Neuro, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

1-for-35Jul 27, 2015

CLPT short interest

How heavily CLPT is shorted: shares short, days to cover and average daily volume.

Days to cover: 6.0
Short interest: 4.76M
Avg volume: 792.18K

As of Sep 30, 2026 · reported to FINRA twice monthly.

CLPT news

The latest news and headlines about ClearPoint Neuro, Inc. Common Stock (CLPT).

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
positiveZacks Investment Research· Oct 26, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
negativeGlobeNewswire Inc.· Oct 13, 2026
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
neutralZacks Investment Research· Oct 8, 2026
Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI
neutralGlobeNewswire Inc.· Nov 20, 2024
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
GlobeNewswire Inc.· Jun 20, 2024

Frequently asked questions

What is the ClearPoint Neuro, Inc. Common Stock (CLPT) stock price today?

ClearPoint Neuro, Inc. Common Stock (CLPT) is trading at $9.04 (-1.09% on the day) as of 4:10:04 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is ClearPoint Neuro, Inc. Common Stock?

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain.

What is the short interest in CLPT?

As of Sep 30, 2026, CLPT has 4.76M shares short and 6.0 days to cover.

What exchange is CLPT listed on?

ClearPoint Neuro, Inc. Common Stock (CLPT) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

Build with AI

Build an analysis of CLPT with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Claude ChatGPT

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CLPT analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.